Hansson O

Proteomic changes in Alzheimer's disease associated with progressive Aβ plaque and tau tangle pathologies.

Pichet Binette A, Gaiteri C, Wennström M, ..., Vogel JW, Hansson O

Nat. Neurosci. 27 (10) 1880-1891 [2024-10-00; online 2024-08-26]

DDLS Fellow Jacob W Vogel

A generalizable data-driven model of atrophy heterogeneity and progression in memory clinic settings.

Baumeister H, Vogel JW, Insel PS, ..., Hansson O, Berron D

Brain 147 (7) 2400-2413 [2024-07-05; online 2024-04-24]

DDLS Fellow Jacob W Vogel

Disease progression modelling reveals heterogeneity in trajectories of Lewy-type α-synuclein pathology.

Mastenbroek SE, Vogel JW, Collij LE, ..., Beach TG, Hansson O

Nat Commun 15 (1) 5133 [2024-06-15; online 2024-06-15]

DDLS Fellow Jacob W Vogel

Cerebrospinal fluid reference proteins increase accuracy and interpretability of biomarkers for brain diseases.

Karlsson L, Vogel J, Arvidsson I, ..., Mattsson-Carlgren N, Hansson O

Nat Commun 15 (1) 3676 [2024-05-01; online 2024-05-01]

DDLS Fellow Jacob W Vogel

Disease staging of Alzheimer's disease using a CSF-based biomarker model.

Salvadó G, Horie K, Barthélemy NR, ..., Bateman RJ, Hansson O

Nat Aging 4 (5) 694-708 [2024-05-00; online 2024-03-21]

DDLS Fellow Jacob W Vogel

Biomarker-based staging of Alzheimer disease: rationale and clinical applications.

Therriault J, Schindler SE, Salvadó G, ..., Jack CR, Rosa-Neto P

Nat Rev Neurol 20 (4) 232-244 [2024-04-00; online 2024-03-01]

DDLS Fellow Jacob W Vogel

Data-driven neuropathological staging and subtyping of TDP-43 proteinopathies.

Young AL, Vogel JW, Robinson JL, ..., Lee EB, Hansson O

Brain - (-) - [2023-05-08; online 2023-05-08]

DDLS Fellow Jacob W Vogel